Provided by Tiger Trade Technology Pte. Ltd.

Vertex, Inc.

12.09
-0.2500-2.03%
Volume:4.19M
Turnover:50.91M
Market Cap:1.93B
PE:302.25
High:12.45
Open:12.36
Low:12.04
Close:12.34
52wk High:48.00
52wk Low:11.96
Shares:159.53M
Float Shares:70.11M
Volume Ratio:0.83
T/O Rate:5.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0400
EPS(LYR):0.0400
ROE:3.29%
ROA:-0.40%
PB:7.45
PE(LYR):302.25

Loading ...

Jeffrey Westphal Reports Acquisition of Vertex Inc. Common Shares

Reuters
·
11 hours ago

Stock Track | Vertex Inc. Soars 10.34% in After-Hours on Beneficial Owner Share Acquisition

Stock Track
·
11 hours ago

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
12 hours ago

Analysts Conflicted on These Healthcare Names: Baxter International (BAX), Labcorp Holdings (LH) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Yesterday

Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Yesterday

Vertex Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 17

HC Wainwright Adjusts Price Target on Vertex Pharmaceuticals to $591 From $518, Maintains Buy Rating

MT Newswires Live
·
Feb 17

Vertex Pharmaceuticals price target raised to $591 from $518 at H.C. Wainwright

TIPRANKS
·
Feb 17

Vertex Pharmaceuticals (VRTX) Gets a Buy from Barclays

TIPRANKS
·
Feb 17

Why Vertex Pharmaceuticals (VRTX) Is Up 6.0% After Profit Rebound And Non-CF Pipeline Update - And What's Next

Simply Wall St.
·
Feb 17

Vertex Minerals Secures New South Wales Exploration License; Shares Hit Over One-Year Low

MT Newswires Live
·
Feb 17

Vertex, Inc. Earnings Call Highlights Cloud and AI Momentum

TIPRANKS
·
Feb 16

Is Vertex Pharmaceuticals (VRTX) Still Attractive After Strong Multi Year Share Price Gains

Simply Wall St.
·
Feb 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX) and 10x Genomics (TXG)

TIPRANKS
·
Feb 15

Vertex Pharmaceuticals Inc. Stock Rallies 5.7%, Outperforms Peers

Dow Jones
·
Feb 14

Vertex Pharmaceuticals Up Over 6%, On Track for Highest Close Since May 2025 -- Data Talk

Dow Jones
·
Feb 14

Vertex Pharmaceuticals Q4 'Anticlimactic' on Pipeline, 2026 Guide Reinforces Core Strength, RBC Says

MT Newswires Live
·
Feb 14

Vertex Pharmaceuticals' Therapies for Kidney Diseases Could Diversify Long-Term Revenue Streams, Oppenheimer Says

MT Newswires Live
·
Feb 14

Analysts Have Conflicting Sentiments on These Healthcare Companies: Organon (OGN), Maravai Lifesciences Holdings (MRVI) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Feb 13

Vertex Pharmaceuticals price target raised to $558 from $495 at Scotiabank

TIPRANKS
·
Feb 13